Fluidigm (FLDM) R&D EVP Unger to Take Leave of Absence
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
Fluidigm (NASDAQ: FLDM) disclosed the following in a U.S. SEC filing on Tuesday:
Item 5.02 – Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On September 7, 2016, Marc Unger, our Executive Vice President, Research and Development and Marketing, indicated his decision to take an approximately 10-week leave of absence from Fluidigm Corporation (the “Company”) commencing October 1, 2016. The Company and Dr. Unger intend to enter into a part-time consulting engagement, commencing in December 2016 following Dr. Unger’s leave, and are currently in discussions regarding the terms of the leave and such consulting or other arrangement.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amec Foster Wheeler (AMFW) Provides Update; Notes FX-Driven Boost to FY16/17 Reported Numbers
- Ritter Pharmaceuticals (RTTR) Prices 2.13M Share Common Offering for Proceeds of $5M
- AK Steel (AKS) to Offer 65M Shares
Create E-mail Alert Related CategoriesCorporate News, Management Changes
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!